153 related articles for article (PubMed ID: 7867690)
1. Modification of hepatic cytochrome P450 profile by cocaine-induced hepatotoxicity in DBA/2 mouse.
Pellinen P; Stenbäck F; Raunio H; Pelkonen O; Pasanen M
Eur J Pharmacol; 1994 Nov; 292(1):57-65. PubMed ID: 7867690
[TBL] [Abstract][Full Text] [Related]
2. Regenerative changes in hepatic morphology and enhanced expression of CYP2B10 and CYP3A during daily administration of cocaine.
Pellinen P; Stenbäck F; Kojo A; Honkakoski P; Gelboin HV; Pasanen M
Hepatology; 1996 Mar; 23(3):515-23. PubMed ID: 8617431
[TBL] [Abstract][Full Text] [Related]
3. Response of mouse liver coumarin 7-hydroxylase activity to hepatotoxins: dependence on strain and agent and comparison to other monooxygenases.
Pellinen P; Stenbäck F; Rautio A; Pelkonen O; Lang M; Pasanen M
Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct; 348(4):435-43. PubMed ID: 8277979
[TBL] [Abstract][Full Text] [Related]
4. Acute cadmium chloride administration induces hepatic and renal CYP2A5 mRNA, protein and activity in the mouse: involvement of transcription factor NRF2.
Abu-Bakar A; Satarug S; Marks GC; Lang MA; Moore MR
Toxicol Lett; 2004 Mar; 148(3):199-210. PubMed ID: 15041070
[TBL] [Abstract][Full Text] [Related]
5. The inhibition of CYP enzymes in mouse and human liver by pilocarpine.
Kimonen T; Juvonen RO; Alhava E; Pasanen M
Br J Pharmacol; 1995 Feb; 114(4):832-6. PubMed ID: 7773543
[TBL] [Abstract][Full Text] [Related]
6. The role of stress in the regulation of drug metabolizing enzymes in mice.
Konstandi M; Marselos M; Radon-Camus AM; Johnson E; Lang MA
Eur J Drug Metab Pharmacokinet; 1998; 23(4):483-90. PubMed ID: 10323331
[TBL] [Abstract][Full Text] [Related]
7. Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5.
Abu-Bakar A; Moore MR; Lang MA
Biochem Pharmacol; 2005 Nov; 70(10):1527-35. PubMed ID: 16183037
[TBL] [Abstract][Full Text] [Related]
8. Liver injury and expression of cytochromes P450: evidence that regulation of CYP2A5 is different from that of other major xenobiotic metabolizing CYP enzymes.
Camus-Randon AM; Raffalli F; Béréziat JC; McGregor D; Konstandi M; Lang MA
Toxicol Appl Pharmacol; 1996 May; 138(1):140-8. PubMed ID: 8658503
[TBL] [Abstract][Full Text] [Related]
9. Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitors.
Pellinen P; Honkakoski P; Stenbäck F; Niemitz M; Alhava E; Pelkonen O; Lang MA; Pasanen M
Eur J Pharmacol; 1994 Jan; 270(1):35-43. PubMed ID: 8157080
[TBL] [Abstract][Full Text] [Related]
10. Sex and strain differences in mouse hepatic microsomal coumarin 7-hydroxylase activity.
van Iersel M; Walters DG; Price RJ; Lovell DP; Lake BG
Food Chem Toxicol; 1994 Apr; 32(4):387-90. PubMed ID: 8206435
[TBL] [Abstract][Full Text] [Related]
11. Cerium-induced strain-dependent increase in Cyp2a-4/5 (cytochrome P4502a-4/5) expression in the liver and kidneys of inbred mice.
Salonpää P; Iscan M; Pasanen M; Arvela P; Pelkonen O; Raunio H
Biochem Pharmacol; 1992 Oct; 44(7):1269-74. PubMed ID: 1417950
[TBL] [Abstract][Full Text] [Related]
12. Circadian expression of the steroid 15 alpha-hydroxylase (Cyp2a4) and coumarin 7-hydroxylase (Cyp2a5) genes in mouse liver is regulated by the PAR leucine zipper transcription factor DBP.
Lavery DJ; Lopez-Molina L; Margueron R; Fleury-Olela F; Conquet F; Schibler U; Bonfils C
Mol Cell Biol; 1999 Oct; 19(10):6488-99. PubMed ID: 10490589
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of CYP2A5 expression by porphyrinogenic agents in mouse liver.
Salonpää P; Krause K; Pelkonen O; Raunio H
Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):446-52. PubMed ID: 7543189
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of a microsomal cytochrome P-450 with high activity of coumarin 7-hydroxylase from mouse liver.
Kaipainen P; Nebert DW; Lang MA
Eur J Biochem; 1984 Nov; 144(3):425-31. PubMed ID: 6436023
[TBL] [Abstract][Full Text] [Related]
15. Induction of CYP2A5 by pyrazole and its derivatives in mouse primary hepatocytes.
Kojo A; Viitala P; Pasanen M; Pelkonen O; Raunio H; Juvonen R
Arch Toxicol; 1998 May; 72(6):336-41. PubMed ID: 9657280
[TBL] [Abstract][Full Text] [Related]
16. Distinct responses of mouse hepatic CYP enzymes to corn oil and peroxisome proliferators.
Kojo A; Pellinen P; Juvonen R; Raunio H; Pelkonen O; Pasanen M
Biochem Pharmacol; 1996 May; 51(9):1137-43. PubMed ID: 8645335
[TBL] [Abstract][Full Text] [Related]
17. Induction of CYP2B1 and 3A1, and associated monoxygenase activities by tamoxifen and certain analogues in the livers of female rats and mice.
White IN; Davies A; Smith LL; Dawson S; De Matteis F
Biochem Pharmacol; 1993 Jan; 45(1):21-30. PubMed ID: 8424814
[TBL] [Abstract][Full Text] [Related]
18. The cerium-induced liver injury and oxidative drug metabolism in DBA/2 and C57BL/6 mice.
Arvela P; Kraul H; Stenbäck F; Pelkonen O
Toxicology; 1991; 69(1):1-9. PubMed ID: 1926150
[TBL] [Abstract][Full Text] [Related]
19. Differential xenobiotic induction of CYP2A5 in mouse liver, kidney, lung, and olfactory mucosa.
Su T; He W; Gu J; Lipinskas TW; Ding X
Drug Metab Dispos; 1998 Aug; 26(8):822-4. PubMed ID: 9698299
[TBL] [Abstract][Full Text] [Related]
20. Biphasic response for hepatic microsomal enzyme induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice.
Shen ES; Guengerich FP; Olson JR
Biochem Pharmacol; 1989 Nov; 38(22):4075-84. PubMed ID: 2512931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
